BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2008
View Archived Issues
IGF-I elevations last over one week after single injection of NNC-126-0083
Read More
Recent AstraZeneca patents describe new imaging agents
Read More
CNTO-328 demonstrates activity in ovarian cancer trial
Read More
New p38alpha MAPK inhibitors disclosed in recent Almirall patent
Read More
Recent Takeda patent reports new 5-HT2C receptor agonists for urinary incontinence
Read More
Diabetes candidate ARRY-403 to advance to clinical investigation
Read More
Ranbaxy submits IND in India to initiate phase I trials of respiratory inflammation candidate
Read More
Vernalis receives milestone payment from Servier under oncology drug program
Read More
Acusphere's Imagify to be reviewed at FDA Advisory Committee Meeting in December 2008
Read More
New agents for treating endocrine disorders divulged in recent patent literature
Read More
King Pharmaceuticals extends tender offer until November 2008 to acquire Alpharma
Read More
PharmAthene raises USD 13.1 million in strategic equity financing with Panacea Biotec
Read More
NVA-237 provides bronchodilation to COPD patients in phase II studies
Read More
Differin gel to be launched in Japan for topical treatment of acne vulgaris
Read More
Dr. Reddy's subsidiary launches EpiCeram skin barrier emulsion
Read More
Lisofylline to be studied in phase II trial to improve islet cell transplant outcomes
Read More
Omrix receives EMEA approval for Evicel liquid fibrin sealant
Read More
Pfizer launches Macugen for age-related macular degeneration in Japan
Read More
Acura and King present top-line results for Acurox in abuse liability
Read More
Neurogen reports results from phase II trials of aplindore in RLS and PD
Read More
Nile reports interim data from phase IIa CD-NP study in heart failure
Read More
TB Alliance and sanofi aventis enter collaboration for new TB drugs
Read More
MMRC initiates phase Ib study of elotuzumab in combination with Revlimid and dexamethasone
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Orexigen Therapeutics
Read More
Overall survival and safety data on elesclomol reported
Read More